Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica A Roesch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pediatric Pulmonology|September 30, 2017
Powerful tools for genetic modification: Advances in gene editingErica A Roesch, Mitchell L Drumm
Expert Review of Respiratory Medicine|March 23, 2022
The use of tobramycin for Pseudomonas aeruginosa: a reviewStanley B Fiel, Erica A Roesch
Pediatric Pulmonology|July 13, 2018
Inflammation in cystic fibrosis: An updateErica A Roesch, David P Nichols, James F Chmiel
Current Opinion in Pulmonary Medicine|August 23, 2023
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulatorsKatherine E Wajda, Erica A Roesch, Alex H Gifford
Expert Review of Respiratory Medicine|August 23, 2024
The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulatorsErica A Roesch, Abdelkader Rahmaoui, Robert A Lazarus, et al.
Frontiers in Pediatrics|November 7, 2024
Case Report: A delicate equilibrium of exocrine pancreatic recovery and hepatotoxicity with elexacaftor/tezacaftor/ivacaftor therapy in a pediatric patient with cystic fibrosisMichael P Coughlin, Senthilkumar Sankararaman, Erica A Roesch, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the "First in Cystic Fibrosis" Phase I Clinical Trial (CEASE-CF)Tracey L Bonfield, Morgan T Sutton, David R Fletcher, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 26, 2019
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networksShuyu Hao, Erica A Roesch, Aura Perez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 22, 2022
A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosisErica A Roesch, Tracey L Bonfield, Hillard M Lazarus, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pediatric Pulmonology|September 30, 2017
Powerful tools for genetic modification: Advances in gene editingErica A Roesch, Mitchell L Drumm
Expert Review of Respiratory Medicine|March 23, 2022
The use of tobramycin for Pseudomonas aeruginosa: a reviewStanley B Fiel, Erica A Roesch
Pediatric Pulmonology|July 13, 2018
Inflammation in cystic fibrosis: An updateErica A Roesch, David P Nichols, James F Chmiel
Current Opinion in Pulmonary Medicine|August 23, 2023
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulatorsKatherine E Wajda, Erica A Roesch, Alex H Gifford
Expert Review of Respiratory Medicine|August 23, 2024
The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulatorsErica A Roesch, Abdelkader Rahmaoui, Robert A Lazarus, et al.
Frontiers in Pediatrics|November 7, 2024
Case Report: A delicate equilibrium of exocrine pancreatic recovery and hepatotoxicity with elexacaftor/tezacaftor/ivacaftor therapy in a pediatric patient with cystic fibrosisMichael P Coughlin, Senthilkumar Sankararaman, Erica A Roesch, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the "First in Cystic Fibrosis" Phase I Clinical Trial (CEASE-CF)Tracey L Bonfield, Morgan T Sutton, David R Fletcher, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 26, 2019
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networksShuyu Hao, Erica A Roesch, Aura Perez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 22, 2022
A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosisErica A Roesch, Tracey L Bonfield, Hillard M Lazarus, et al.
Pageof 1